TEVA: TEVA PHARMACEUTICAL INDS LTD Profile

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets open in 11 hrs, 48 mins

Symbol	Value	Change	Percentage Change
DJIA	11,288.54	73.03	0.65%
NASDAQ	2,245.38	-6.08	-0.27%
S&P 500	1,262.90	1.38	0.11%

TEVA PHARMACEUTICAL INDS LTD

TEVA

Stock price

47.20 0.27 0.58%

as of 01:00 PM EDT on 07/03/2008 in USD (NASDAQ Delay: 15 mins.)
Extended Hours

— — —

Analyst Consensus

Buy
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: TEVA

Insightful information about industries, companies, and the people who lead them.

Learn More.

2007 Sales	2007 Sales Growth	2007 Net Income	2006 Employees
$9,408,000,000	11.9%	$1,952,000,000	26,700

Key Executives: TEVA

Name	Title	Officer Since
Shlomo Yanai	CEO	-
Dan S. Suesskind	CFO	-
Rodney Kasan	Chief Technology Officer	-
Uzi Karniel	General Counsel	-
Abraham E. Cohen	Director	1/1/92
Professor Roger D. Kornberg, Ph.D.	Director	1/1/07
Isaac ( Ika) Abravanel	Vice President, Divisional	-
Dan Propper	Director	1/1/07

View All Key Executives

Abraham E. Cohen served as Senior Vice President of Merck & Co. from 1982 to 1992 and from 1977 to 1988 as President of the Merck Sharp & Dohme International Division. Since his retirement in January 1992, Mr. Cohen has been active as an international business consultant. He served as a director of Akzo Nobel NV until 2007. He is presently a director of Chugai Pharmaceutical Co. U.S.A., Neurobiological Technologies, Inc. and Vasomedical, Inc.... View Full Profile

Abraham E. Cohen

Prof. Roger D. Kornberg is the Winzer Professor in Medicine in the Department of Structural Biology at Stanford University, where he has been a professor since 1978. Prior to joining Stanford, he served as a professor at Harvard Medical School. Prof. Kornberg received a B.A. degree from Harvard in 1967 and a Ph.D. degree in chemistry from Stanford in 1972. He has received many awards, including the Welch Prize (2001), the highest award in... View Full Profile

Professor Roger D. Kornberg, Ph.D.

Isaac (Ika) Abravanel joined Teva in September 2007 as Corporate Vice President-Human Resources. From 2005 to 2007, he served as Deputy CEO of Bezeq Israel Telecommunications Co. Ltd., responsible for operations, the business sector, the private sector, and human resources, and from 2001 to 2005, was the Senior VP of Operations & Customer Service at Pelephone Communications Ltd. From 1998 to 2000, he held the position of Executive Director of... View Full Profile

Isaac ( Ika) Abravanel

Dan Propper is the Chairman of the Board of Osem Investments Ltd., a leading Israeli manufacturer of food products. Mr. Propper served as the Chief Executive Officer of Osem for 25 years until April 2006. In addition to his role at Osem, from 1993 until 1999, Mr. Propper served as President of the Manufacturers Association of Israel, an independent umbrella organization representing industrial enterprises in Israel, and as Chairman of the... View Full Profile

Dan Propper

Aharon (Arik) Yaari has served as Group Vice President-Global API division since January 2006. Mr. Yaari served as Vice President-Global API Division from 2002 until January 2006. Mr. Yaari joined Teva in 1981 and among his various assignments at Teva he served as Vice President-Marketing and Sales of Teva API Division from 1999 to 2002 and President of Plantex USA from 1996 to 1999. He received (cum laude) his B.A. and M.A. in economics from the... View Full Profile

Aharon (Arik) Yaari

Bruria Sofrin joined Teva in August 2004 as Corporate Vice President- Human Resources. Prior to joining Teva, Ms. Sofrin held senior positions as Director of Human Resources at Hewlett-Packard in Europe and in Israel. Prior to joining Hewlett-Packard in 1984, Ms. Sofrin served as Director of Human Resources at National Semiconductor in Israel for three years. Ms. Sofrin received her B.A. in psychology and studied for an M.A. in social and... View Full Profile

Bruria Sofrin

Dr. Shmuel (Muli) Ben-Zvi has been Teva's Vice President- Planning, Economics & IT since October 2004. Prior to joining Teva, Dr. Ben-Zvi served as the Financial Advisor to the Chief of Staff of the IDF and as the Head of the Budget Department of the Israel Ministry of Defense from 2000 until 2004, and prior to 2000 held several senior positions in the Budget Department of the Ministry of Defense. In 1986, Dr. Ben-Zvi received a Ph.D in economics... View Full Profile

Dr.Shmuel (Muli) Ben-Zvi

Doron Blachar has been Teva's Vice President- Finance since February 2005. Mr. Blachar previously held several senior financial positions at Amdocs Limited from 1998 to 2005, the last as Vice President Finance. He was responsible for the Amdocs financial organization and was involved in Amdocs' convertible debt offering, merger and acquisition activities and various other financial operations. Mr. Blachar is a Certified Public Accountant (Isr).... View Full Profile

Doron Blachar

William S. Marth has served as President and Chief Executive Officer of Teva North America since January 21, 2008 and as President and Chief Executive Officer of Teva USA since January 2005. He previously served as Executive Vice President of Teva USA from January 2002 to January 2005. From July 1999 to January 2002, he served as Vice President of Sales and Marketing for Teva USA. Prior to joining Teva USA, he served in various positions with the... View Full Profile

William S. Marth

Ron Grupel has been the Internal Auditor of Teva since 1993. He received his B.A. in economics and accounting in 1975 and his M.B.A. in 1979 from Tel Aviv University.... View Full Profile

Ron Grupel

David Shamir has served as the General Manager of Texas Instruments Israel Ltd. since 2001. From 1986 to 2001, he served in several R&D and management positions in Motorola Semiconductor Israel Ltd. He received his B.Sc. in computer engineering from the Technion-Israel Institute of Technology in 1986.... View Full Profile

David Shamir

Dr. Itzhak Krinsky joined Teva as Corporate Vice President for Business Development in May 2005. Prior to joining Teva, Dr. Krinsky was a managing director with The Silverfern Group, Inc. from January 2003 until February 2005 and until joining Teva, he was also a managing director with Trenwith Securities, LLC, both investment banking boutiques in New York City. From July 2001 until December 2002, Dr. Krinsky was a managing director of I.... View Full Profile

Dr. Itzhak Krinsky, Ph.D.

Dr. Gerard W.M. Van Odijk joined Teva as Group Vice President-Europe and President and CEO of Teva Pharmaceutical Europe B.V. in January 2006. Over the previous 18 years, he held a variety of senior positions in Europe at Glaxo, GlaxoWellcome and GlaxoSmithKline and served in commercial and General Management positions in France, the United Kingdom and The Netherlands. Prior to joining Teva, Dr. Van Odijk was Senior Vice President and Area... View Full Profile

Dr. Gerard W.M. Van Odijk, M.D.

Dr. Shosh Neumann has been with Teva since March 1988. Dr. Neumann has served as Vice President- Product Portfolio Management since January 2006. Previously, she was executive director of Israel Generic Research and Development from July 2000 to January 2006, served in various management positions in Quality Assurance from 1995 to 2000 and as manager in Research and Development from 1988 to 1995. Dr. Neumann received her Ph.D. in chemistry from... View Full Profile

Dr.Shosh Neumann

Judith Vardi has been with Teva since 1985. Ms. Vardi has served as Vice President- Israel Pharmaceutical Sales since January 2006. She served as the General Manager for the Prescription Medicines and Health Fund Division in Teva Israel from November 2002 to 2005. From 1994 to 2002, Ms. Vardi held various positions within the Global Products Division, and from 1990 to 1994, she served as the General Manager of Farmaquim Ltd., a subsidiary of Teva... View Full Profile

Judith Vardi

Dr. Phillip Frost has served as Vice Chairman of the Board of Teva since the completion of the acquisition of Ivax Corporation in January 2006 and as Chairman of the Board and Chief Executive Officer of Ivax from 1987 until 2006. He was also President of Ivax from 1991 until 1995. Dr. Frost presently serves as the Chairman of the Board and CEO of Opko Health, Inc., a specialty pharmaceutical company, and as Chairman of the Board for Ladenburg

Live Updates:

Ticker

Dynamic view of the market

TEVA PHARMACEUTICAL INDS LTD

TEVA

Stock price

Extended Hours

Analyst Consensus

TEVA PHARMACEUTICAL INDS LTD Profile

Key Executives: TEVA